Global Peripheral Blood Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

TABLE OF CONTENTS

1 Report Overview

• 1.1 Research Scope
• 1.2 Market Segment by Type
  • 1.2.1 Global Peripheral Blood Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
  • 1.2.2 Leukopak
  • 1.2.3 Stem Cells
  • 1.2.4 PBMCs
  • 1.2.5 Others
• 1.3 Market Segment by Application
  • 1.3.1 Global Peripheral Blood Market Share by Application (2017 VS 2021 VS 2028)
  • 1.3.2 Disease Treatment
  • 1.3.3 Research and Development
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Market Perspective

• 2.1 Global Peripheral Blood Market Size (2017-2028)
  • 2.1.1 Global Peripheral Blood Revenue (2017-2028)
  • 2.1.2 Global Peripheral Blood Sales (2017-2028)
• 2.2 Global Peripheral Blood Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
  • 2.2.1 Global Peripheral Blood Sales by Regions (2017-2022)
  • 2.2.2 Global Peripheral Blood Revenue by Regions (2017-2022)
• 2.3 Global Peripheral Blood Market Size Forecast by Region
  • 2.3.1 Global Peripheral Blood Sales Forecast by Region (2023-2028)
  • 2.3.2 Global Peripheral Blood Revenue Forecast by Region (2023-2028)
• 2.4 Global Top Peripheral Blood Regions (Countries) Ranking by Market Size
• 2.5 Peripheral Blood Market Dynamics
  • 2.5.1 Peripheral Blood Market Trends
  • 2.5.2 Peripheral Blood Market Drivers
  • 2.5.3 Peripheral Blood Market Challenges
  • 2.5.4 Peripheral Blood Market Restraints

3 Competitive Landscape by Manufacturers

• 3.1 Global Top Peripheral Blood Manufacturers by Sales (2017-2022)
  • 3.1.1 Global Peripheral Blood Sales by Manufacturers (2017-2022)
  • 3.1.2 Global Peripheral Blood Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global 5 and 10 Largest Manufacturers by Peripheral Blood Sales in 2021
• 3.2 Global Top Manufacturers Peripheral Blood by Revenue
  • 3.2.1 Global Peripheral Blood Revenue by Manufacturers (2017-2022)
  • 3.2.2 Top Peripheral Blood Manufacturers Covered: Ranking by Revenue
  • 3.2.3 Global Peripheral Blood Revenue Share by Manufacturers (2017-2022)
  • 3.2.4 Global Peripheral Blood Market Concentration Ratio (CR5 and HHI)
• 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Blood as of 2021)
• 3.4 Global Peripheral Blood Average Selling Price (ASP) by Manufacturers
• 3.5 Key Manufacturers Peripheral Blood Plants/Factories Distribution and Area Served
• 3.6 Date of Key Manufacturers Enter into Peripheral Blood Market
• 3.7 Key Manufacturers Peripheral Blood Product Offered
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Peripheral Blood Market Size by Type

• 4.1 Global Peripheral Blood Historic Market Review by Type (2017-2022)
  • 4.1.1 Global Peripheral Blood Sales Market Share by Type (2017-2022)
  • 4.1.2 Global Peripheral Blood Revenue Market Share by Type (2017-2022)
  • 4.1.3 Peripheral Blood Price by Type (2017-2022)
• 4.2 Global Peripheral Blood Market Estimates and Forecasts by Type (2023-2028)
  • 4.2.1 Global Peripheral Blood Sales Forecast by Type (2023-2028)
  • 4.2.2 Global Peripheral Blood Revenue Forecast by Type (2023-2028)
  • 4.2.3 Peripheral Blood Price Forecast by Type (2023-2028)

5 Global Peripheral Blood Market Size by Application

• 5.1 Global Peripheral Blood Historic Market Review by Application (2017-2022)
  • 5.1.1 Global Peripheral Blood Sales Market Share by Application (2017-2022)
  • 5.1.2 Global Peripheral Blood Revenue Market Share by Application (2017-2022)
  • 5.1.3 Peripheral Blood Price by Application (2017-2022)
• 5.2 Global Peripheral Blood Market Estimates and Forecasts by Application (2023-2028)
  • 5.2.1 Global Peripheral Blood Sales Forecast by Application (2023-2028)
  • 5.2.2 Global Peripheral Blood Revenue Forecast by Application (2023-2028)
  • 5.2.3 Peripheral Blood Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Peripheral Blood Sales Breakdown by Company
  • 6.1.1 North America Peripheral Blood Sales by Company (2017-2022)
  • 6.1.2 North America Peripheral Blood Revenue by Company (2017-2022)
• 6.2 North America Peripheral Blood Market Size by Type
  • 6.2.1 North America Peripheral Blood Sales by Type (2017-2028)
  • 6.2.2 North America Peripheral Blood Revenue by Type (2017-2028)
• 6.3 North America Peripheral Blood Market Size by Application
  • 6.3.1 North America Peripheral Blood Sales by Application (2017-2028)
  • 6.3.2 North America Peripheral Blood Revenue by Application (2017-2028)
• 6.4 North America Peripheral Blood Market Size by Country
  • 6.4.1 North America Peripheral Blood Sales by Country (2017-2028)
  • 6.4.2 North America Peripheral Blood Revenue by Country (2017-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Peripheral Blood Sales Breakdown by Company
  • 7.1.1 Europe Peripheral Blood Sales by Company (2017-2022)
  • 7.1.2 Europe Peripheral Blood Revenue by Company (2017-2022)
• 7.2 Europe Peripheral Blood Market Size by Type
  • 7.2.1 Europe Peripheral Blood Sales by Type (2017-2028)
  • 7.2.2 Europe Peripheral Blood Revenue by Type (2017-2028)
• 7.3 Europe Peripheral Blood Market Size by Application
  • 7.3.1 Europe Peripheral Blood Sales by Application (2017-2028)
  • 7.3.2 Europe Peripheral Blood Revenue by Application (2017-2028)
• 7.4 Europe Peripheral Blood Market Size by Country
  • 7.4.1 Europe Peripheral Blood Sales by Country (2017-2028)
  • 7.4.2 Europe Peripheral Blood Revenue by Country (2017-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Peripheral Blood Sales Breakdown by Company
  • 8.1.1 Asia Pacific Peripheral Blood Sales by Company (2017-2022)
  • 8.1.2 Asia Pacific Peripheral Blood Revenue by Company (2017-2022)
• 8.2 Asia Pacific Peripheral Blood Market Size by Type
  • 8.2.1 Asia Pacific Peripheral Blood Sales by Type (2017-2028)
  • 8.2.2 Asia Pacific Peripheral Blood Revenue by Type (2017-2028)
• 8.3 Asia Pacific Peripheral Blood Market Size by Application
  • 8.3.1 Asia Pacific Peripheral Blood Sales by Application (2017-2028)
  • 8.3.2 Asia Pacific Peripheral Blood Revenue by Application (2017-2028)
• 8.4 Asia Pacific Peripheral Blood Market Size by Region
  • 8.4.1 Asia Pacific Peripheral Blood Sales by Region
  • 8.4.2 Asia Pacific Peripheral Blood Revenue by Region
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 India
  • 8.4.7 Australia
  • 8.4.8 Taiwan
  • 8.4.9 Indonesia
  • 8.4.10 Thailand
  • 8.4.11 Malaysia
  • 8.4.12 Philippines
  • 8.4.13 Vietnam

9 Latin America

• 9.1 Latin America Peripheral Blood Sales Breakdown by Company
  • 9.1.1 Latin America Peripheral Blood Sales by Company (2017-2022)
  • 9.1.2 Latin America Peripheral Blood Revenue by Company (2017-2022)
• 9.2 Latin America Peripheral Blood Market Size by Type
  • 9.2.1 Latin America Peripheral Blood Sales by Type (2017-2028)
  • 9.2.2 Latin America Peripheral Blood Revenue by Type (2017-2028)
• 9.3 Latin America Peripheral Blood Market Size by Application
  • 9.3.1 Latin America Peripheral Blood Sales by Application (2017-2028)
  • 9.3.2 Latin America Peripheral Blood Revenue by Application (2017-2028)
• 9.4 Latin America Peripheral Blood Market Size by Country
  • 9.4.1 Latin America Peripheral Blood Sales by Country (2017-2028)
  • 9.4.2 Latin America Peripheral Blood Revenue by Country (2017-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil
  • 9.4.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Peripheral Blood Sales Breakdown by Company
  • 10.1.1 Middle East and Africa Peripheral Blood Sales by Company (2017-2022)
  • 10.1.2 Middle East and Africa Peripheral Blood Revenue by Company (2017-2022)
• 10.2 Middle East and Africa Peripheral Blood Market Size by Type
  • 10.2.1 Middle East and Africa Peripheral Blood Sales by Type (2017-2028)
  • 10.2.2 Middle East and Africa Peripheral Blood Revenue by Type (2017-2028)
• 10.3 Middle East and Africa Peripheral Blood Market Size by Application
  • 10.3.1 Middle East and Africa Peripheral Blood Sales by Application (2017-2028)
  • 10.3.2 Middle East and Africa Peripheral Blood Revenue by Application (2017-2028)
• 10.4 Middle East and Africa Peripheral Blood Market Size by Country
  • 10.4.1 Middle East and Africa Peripheral Blood Sales by Country (2017-2028)
  • 10.4.2 Middle East and Africa Peripheral Blood Revenue by Country (2017-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 U.A.E

11 Company Profiles

• 11.1 HemaCare
  • 11.1.1 HemaCare Corporation Information
  • 11.1.2 HemaCare Overview
  • 11.1.3 HemaCare Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.1.4 HemaCare Peripheral Blood Products and Services
  • 11.1.5 HemaCare Peripheral Blood SWOT Analysis
  • 11.1.6 HemaCare Recent Developments
• 11.2 StemExpress
  • 11.2.1 StemExpress Corporation Information
  • 11.2.2 StemExpress Overview
  • 11.2.3 StemExpress Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.2.4 StemExpress Peripheral Blood Products and Services
  • 11.2.5 StemExpress Peripheral Blood SWOT Analysis
  • 11.2.6 StemExpress Recent Developments
• 11.3 AllCells
  • 11.3.1 AllCells Corporation Information
  • 11.3.2 AllCells Overview
  • 11.3.3 AllCells Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.3.4 AllCells Peripheral Blood Products and Services
  • 11.3.5 AllCells Peripheral Blood SWOT Analysis
  • 11.3.6 AllCells Recent Developments
• 11.4 Mozobil
  • 11.4.1 Mozobil Corporation Information
  • 11.4.2 Mozobil Overview
  • 11.4.3 Mozobil Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
  • 11.4.4 Mozobil Peripheral Blood Products and Services
  • 11.4.5 Mozobil Peripheral Blood SWOT Analysis
  • 11.4.6 Mozobil Recent Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Peripheral Blood Value Chain Analysis
• 12.2 Peripheral Blood Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Peripheral Blood Production Mode & Process
• 12.4 Peripheral Blood Sales and Marketing
  • 12.4.1 Peripheral Blood Sales Channels
  • 12.4.2 Peripheral Blood Distributors
• 12.5 Peripheral Blood Customers

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

• Table 1. Global Peripheral Blood Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Leukopak
• Table 3. Major Manufacturers of Stem Cells
• Table 4. Major Manufacturers of PBMCs
• Table 5. Major Manufacturers of Others
• Table 6. Global Peripheral Blood Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Peripheral Blood Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
• Table 8. Global Peripheral Blood Sales by Region (2017-2022) & (K Units)
• Table 9. Global Peripheral Blood Sales Market Share by Region (2017-2022)
• Table 10. Global Peripheral Blood Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Peripheral Blood Revenue Market Share by Region (2017-2022)
• Table 12. Global Peripheral Blood Sales Forecast by Region (2023-2028) & (K Units)
• Table 13. Global Peripheral Blood Sales Market Share Forecast by Region (2023-2028)
• Table 14. Global Peripheral Blood Revenue Forecast by Region (2023-2028) & (US$ Million)
• Table 15. Global Peripheral Blood Revenue Market Share Forecast by Region (2023-2028)
• Table 16. Top Peripheral Blood Regions (Countries) Ranking by Market Size (US$ Million) in 2021
• Table 17. Peripheral Blood Market Trends
• Table 18. Peripheral Blood Market Drivers
• Table 19. Peripheral Blood Market Challenges
• Table 20. Peripheral Blood Market Restraints
• Table 21. Global Peripheral Blood Sales by Manufacturers (2017-2022) & (K Units)
• Table 22. Global Peripheral Blood Sales Share by Manufacturers (2017-2022)
• Table 23. Global Peripheral Blood Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 24. Ranking of Global Top Peripheral Blood Manufacturers by Revenue (US$ Million) in 2021
• Table 25. Peripheral Blood Revenue Share by Manufacturers (2017-2022)
• Table 26. Global Peripheral Blood Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Blood as of 2021)
• Table 28. Key Manufacturers Peripheral Blood Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
• Table 29. Key Manufacturers Peripheral Blood Plants/Factories Distribution
• Table 30. Key Manufacturers Peripheral Blood Area Served
• Table 31. Date of Key Manufacturers Enter into Peripheral Blood Market
• Table 32. Key Manufacturers Peripheral Blood Product Type
• Table 33. Mergers & Acquisitions, Expansion Plans
• Table 34. Global Peripheral Blood Sales (K Units) by Type (2017-2022)
• Table 35. Global Peripheral Blood Sales Share by Type (2017-2022)
• Table 36. Global Peripheral Blood Revenue (US$ Million) Market Share by Type (2017-2022)
• Table 37. Global Peripheral Blood Price (K Units) by Type (2017-2022)
• Table 38. Global Peripheral Blood Sales (K Units) by Type (2023-2028)
• Table 39. Global Peripheral Blood Sales Share by Type (2023-2028)
• Table 40. Global Peripheral Blood Revenue (US$ Million) Market Share by Type (2023-2028)
• Table 41. Global Peripheral Blood Revenue Share by Type (2023-2028)
• Table 42. Global Peripheral Blood Price (K Units) by Type (2023-2028)
• Table 43. Global Peripheral Blood Sales (K Units) by Application (2017-2022)
• Table 44. Global Peripheral Blood Sales Share by Application (2017-2022)
• Table 45. Global Peripheral Blood Revenue (US$ Million) Market Share by Application (2017-2022)
• Table 46. Global Peripheral Blood Price (K Units) by Application (2017-2022)
• Table 47. Global Peripheral Blood Sales (K Units) by Application (2023-2028)
• Table 48. Global Peripheral Blood Sales Share by Application (2023-2028)
• Table 49. Global Peripheral Blood Revenue (US$ Million) Market Share by Application (2023-2028)
• Table 50. Global Peripheral Blood Revenue Share by Application (2023-2028)
• Table 51. Global Peripheral Blood Price (K Units) by Application (2023-2028)
• Table 52. North America Peripheral Blood Sales by Company (2017-2022) & (K Units)
• Table 53. North America Peripheral Blood Sales Market Share by Company (2017-2022)
• Table 54. North America Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
• Table 55. North America Peripheral Blood Revenue Market Share by Company (2017-2022)
• Table 56. North America Peripheral Blood Sales by Type (2017-2022) & (K Units)
• Table 57. North America Peripheral Blood Sales by Type (2023-2028) & (K Units)
• Table 58. North America Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
• Table 59. North America Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
• Table 60. North America Peripheral Blood Sales by Application (2017-2022) & (K Units)
• Table 61. North America Peripheral Blood Sales by Application (2023-2028) & (K Units)
• Table 62. North America Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
• Table 63. North America Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
• Table 64. North America Peripheral Blood Sales by Country (2017-2022) & (K Units)
• Table 65. North America Peripheral Blood Sales by Country (2023-2028) & (K Units)
• Table 66. North America Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
• Table 67. North America Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
• Table 68. Europe Peripheral Blood Sales by Company (2017-2022) & (K Units)
• Table 69. Europe Peripheral Blood Sales Market Share by Company (2017-2022)
• Table 70. Europe Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
• Table 71. Europe Peripheral Blood Revenue Market Share by Company (2017-2022)
• Table 72. Europe Peripheral Blood Sales by Type (2017-2022) & (K Units)
• Table 73. Europe Peripheral Blood Sales by Type (2023-2028) & (K Units)
• Table 74. Europe Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
• Table 75. Europe Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
• Table 76. Europe Peripheral Blood Sales by Application (2017-2022) & (K Units)
• Table 77. Europe Peripheral Blood Sales by Application (2023-2028) & (K Units)
• Table 78. Europe Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
• Table 79. Europe Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
• Table 80. Europe Peripheral Blood Sales by Country (2017-2022) & (K Units)
• Table 81. Europe Peripheral Blood Sales by Country (2023-2028) & (K Units)
• Table 82. Europe Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
• Table 83. Europe Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
• Table 84. Asia Pacific Peripheral Blood Sales by Company (2017-2022) & (K Units)
• Table 85. Asia Pacific Peripheral Blood Sales Market Share by Company (2017-2022)
• Table 86. Asia Pacific Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
• Table 87. Asia Pacific Peripheral Blood Revenue Market Share by Company (2017-2022)
• Table 88. Asia Pacific Peripheral Blood Sales by Type (2017-2022) & (K Units)
• Table 89. Asia Pacific Peripheral Blood Sales by Type (2023-2028) & (K Units)
• Table 90. Asia Pacific Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
• Table 91. Asia Pacific Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
• Table 92. Asia Pacific Peripheral Blood Sales by Application (2017-2022) & (K Units)
• Table 93. Asia Pacific Peripheral Blood Sales by Application (2023-2028) & (K Units)
• Table 94. Asia Pacific Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
• Table 95. Asia Pacific Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
• Table 96. Asia Pacific Peripheral Blood Sales by Region (2017-2022) & (K Units)
• Table 97. Asia Pacific Peripheral Blood Sales by Region (2023-2028) & (K Units)
• Table 98. Asia Pacific Peripheral Blood Revenue by Region (2017-2022) & (US$ Million)
• Table 99. Asia Pacific Peripheral Blood Revenue by Region (2023-2028) & (US$ Million)
• Table 100. Latin America Peripheral Blood Sales by Company (2017-2022) & (K Units)
• Table 101. Latin America Peripheral Blood Sales Market Share by Company (2017-2022)
• Table 102. Latin America Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
• Table 103. Latin America Peripheral Blood Revenue Market Share by Company (2017-2022)
• Table 104. Latin America Peripheral Blood Sales by Type (2017-2022) & (K Units)
• Table 105. Latin America Peripheral Blood Sales by Type (2023-2028) & (K Units)
• Table 106. Latin America Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
• Table 107. Latin America Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
• Table 108. Latin America Peripheral Blood Sales by Application (2017-2022) & (K Units)
• Table 109. Latin America Peripheral Blood Sales by Application (2023-2028) & (K Units)
• Table 110. Latin America Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
• Table 111. Latin America Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
• Table 112. Latin America Peripheral Blood Sales by Country (2017-2022) & (K Units)
• Table 113. Latin America Peripheral Blood Sales by Country (2023-2028) & (K Units)
• Table 114. Latin America Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
• Table 115. Latin America Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
• Table 116. Middle East and Africa Peripheral Blood Sales by Company (2017-2022) & (K Units)
• Table 117. Middle East and Africa Peripheral Blood Sales Market Share by Company (2017-2022)
• Table 118. Middle East and Africa Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
• Table 119. Middle East and Africa Peripheral Blood Revenue Market Share by Company (2017-2022)
• Table 120. Middle East and Africa Peripheral Blood Sales by Type (2017-2022) & (K Units)
• Table 121. Middle East and Africa Peripheral Blood Sales by Type (2023-2028) & (K Units)
• Table 122. Middle East and Africa Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
• Table 123. Middle East and Africa Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
• Table 124. Middle East and Africa Peripheral Blood Sales by Application (2017-2022) & (K Units)
• Table 125. Middle East and Africa Peripheral Blood Sales by Application (2023-2028) & (K Units)
• Table 126. Middle East and Africa Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
• Table 127. Middle East and Africa Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
• Table 128. Middle East and Africa Peripheral Blood Sales by Country (2017-2022) & (K Units)
• Table 129. Middle East and Africa Peripheral Blood Sales by Country (2023-2028) & (K Units)
• Table 130. Middle East and Africa Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
• Table 131. Middle East and Africa Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
• Table 132. HemaCare Corporation Information
• Table 133. HemaCare Description and Overview
• Table 134. HemaCare Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 135. HemaCare Peripheral Blood Product and Services
• Table 136. HemaCare Peripheral Blood SWOT Analysis
• Table 137. HemaCare Recent Developments
• Table 138. StemExpress Corporation Information
• Table 139. StemExpress Description and Overview
• Table 140. StemExpress Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 141. StemExpress Peripheral Blood Product and Services
• Table 142. StemExpress Peripheral Blood SWOT Analysis
• Table 143. StemExpress Recent Developments
• Table 144. AllCells Corporation Information
• Table 145. AllCells Description and Overview
• Table 146. AllCells Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 147. AllCells Peripheral Blood Product and Services
• Table 148. AllCells Peripheral Blood SWOT Analysis
• Table 149. AllCells Recent Developments
• Table 150. Mozobil Corporation Information
• Table 151. Mozobil Description and Overview
• Table 152. Mozobil Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
• Table 153. Mozobil Peripheral Blood Product and Services
• Table 154. Mozobil Peripheral Blood SWOT Analysis
• Table 155. Mozobil Recent Developments
• Table 156. Key Raw Materials Lists
• Table 157. Raw Materials Key Suppliers Lists
• Table 158. Peripheral Blood Distributors List
• Table 159. Peripheral Blood Customers List
• Table 160. Research Programs/Design for This Report
• Table 161. Key Data Information from Secondary Sources
• Table 162. Key Data Information from Primary Sources

List of Figures

• Figure 1. Peripheral Blood Product Picture
• Figure 2. Global Peripheral Blood Sales Market Share by Type in 2021 & 2028
• Figure 3. Leukopak Product Picture
• Figure 4. Stem Cells Product Picture
• Figure 5. PBMCs Product Picture
• Figure 6. Others Product Picture
• Figure 7. Global Peripheral Blood Sales Market Share by Application in 2021 & 2028
• Figure 8. Disease Treatment Use Case
• Figure 9. Research and Development Use Case
• Figure 10. Other Use Case
• Figure 11. Peripheral Blood Report Years Considered
• Figure 12. Global Peripheral Blood Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Peripheral Blood Market Size 2017-2028 (US$ Million)
• Figure 14. Global Peripheral Blood Sales (2017-2022) & (K Units)
• Figure 15. Global Peripheral Blood Market Size Market Share by Region: 2021 VS 2028
• Figure 16. Global Peripheral Blood Sales Market Share by Region (2017-2022)
• Figure 17. Global Peripheral Blood Sales Market Share by Region in 2021
• Figure 18. Global Peripheral Blood Revenue Market Share by Region in 2017 VS 2021
• Figure 19. Global Peripheral Blood Sales Share by Manufacturers in 2021
• Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Peripheral Blood Sales in 2021
• Figure 21. Peripheral Blood Revenue Share by Manufacturers in 2021
• Figure 22. Peripheral Blood Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
• Figure 23. Global Peripheral Blood Revenue Share by Type (2017-2022)
• Figure 24. Global Peripheral Blood Revenue Growth Rate by Type in 2017 & 2021
• Figure 25. Global Peripheral Blood Revenue Share by Application (2017-2022)
• Figure 26. Global Peripheral Blood Revenue Growth Rate by Application in 2017 & 2021
• Figure 27. North America Peripheral Blood Sales Market Share by Type (2017-2028)
• Figure 28. North America Peripheral Blood Revenue Market Share by Type (2017-2028)
• Figure 29. North America Peripheral Blood Sales Market Share by Application (2017-2028)
• Figure 30. North America Peripheral Blood Revenue Market Share by Application (2017-2028)
• Figure 31. North America Peripheral Blood Sales Share by Country (2017-2028)
• Figure 32. North America Peripheral Blood Revenue Share by Country (2017-2028)
• Figure 33. U.S. Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 34. Canada Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 35. Europe Peripheral Blood Sales Market Share by Type (2017-2028)
• Figure 36. Europe Peripheral Blood Revenue Market Share by Type (2017-2028)
• Figure 37. Europe Peripheral Blood Sales Market Share by Application (2017-2028)
• Figure 38. Europe Peripheral Blood Revenue Market Share by Application (2017-2028)
• Figure 39. Europe Peripheral Blood Sales Share by Country (2017-2028)
• Figure 40. Europe Peripheral Blood Revenue Share by Country (2017-2028)
• Figure 41. Germany Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 42. France Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 43. U.K. Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 44. Italy Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 45. Russia Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 46. Asia Pacific Peripheral Blood Sales Market Share by Type (2017-2028)
• Figure 47. Asia Pacific Peripheral Blood Revenue Market Share by Type (2017-2028)
• Figure 48. Asia Pacific Peripheral Blood Sales Market Share by Application (2017-2028)
• Figure 49. Asia Pacific Peripheral Blood Revenue Market Share by Application (2017-2028)
• Figure 50. Asia Pacific Peripheral Blood Sales Share by Region (2017-2028)
• Figure 51. Asia Pacific Peripheral Blood Revenue Share by Region (2017-2028)
• Figure 52. China Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 53. Japan Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 54. South Korea Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 55. India Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 56. Australia Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 57. Taiwan Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 58. Indonesia Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 59. Thailand Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 60. Malaysia Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 61. Philippines Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 62. Vietnam Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 63. Latin America Peripheral Blood Sales Market Share by Type (2017-2028)
• Figure 64. Latin America Peripheral Blood Revenue Market Share by Type (2017-2028)
• Figure 65. Latin America Peripheral Blood Sales Market Share by Application (2017-2028)
• Figure 66. Latin America Peripheral Blood Revenue Market Share by Application (2017-2028)
• Figure 67. Latin America Peripheral Blood Sales Share by Country (2017-2028)
• Figure 68. Latin America Peripheral Blood Revenue Share by Country (2017-2028)
• Figure 69. Mexico Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 70. Brazil Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 71. Argentina Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 72. Middle East and Africa Peripheral Blood Sales Market Share by Type (2017-2028)
• Figure 73. Middle East and Africa Peripheral Blood Revenue Market Share by Type (2017-2028)
• Figure 74. Middle East and Africa Peripheral Blood Sales Market Share by Application (2017-2028)
• Figure 75. Middle East and Africa Peripheral Blood Revenue Market Share by Application (2017-2028)
• Figure 76. Middle East and Africa Peripheral Blood Sales Share by Country (2017-2028)
• Figure 77. Middle East and Africa Peripheral Blood Revenue Share by Country (2017-2028)
• Figure 78. Turkey Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 79. Saudi Arabia Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 80. U.A.E Peripheral Blood Revenue (2017-2028) & (US$ Million)
• Figure 81. Peripheral Blood Value Chain
• Figure 82. Peripheral Blood Production Process
• Figure 83. Channels of Distribution
• Figure 84. Distributors Profiles
• Figure 85. Bottom-up and Top-down Approaches for This Report
• Figure 86. Data Triangulation
• Figure 87. Key Executives Interviewed